Let’s talk about E-House China Holdings Ltd (EJ).

E- House is a real, complete real-estate proxy play for China's real estate market.  Now, I know, before we get up in arms, it’s been a pretty sloppy market. Even the management of this company admits there’s been a lot of softness in certain cities, and it’s going to linger. But here’s the thing: it can also create opportunities, there’s going to be pricing discounts, there’s probably going to be some relaxed policies -- and all of that generates activity. This company makes a lot of money from that activity, not just the prices of homes going up or down. 

In fact, in the second quarter, they had standout segments including: e-commerce (up 238%), sales agency service (which is traditional up only 5%, but still up in a sloppy market), online real estate (up 97%), real estate information (up 52%). And execution is phenomenal. In the last four quarters they beat the Street by 83%, 43%, 18% -- and the last time out 100%. Revenue was up more than 40%.

I see one more hurdle: $12. After that, I think this stock rallies to $16.

Now, let’s talk about InterMune (ITMN).

InterMune is a biotech company that just received "breakthrough therapy designation" from the Food and Drug Administration for treatment of Idiopathic Pulmonary Fibrosis (IPF). This designation – given to treatments of patients in serious or life-threatening conditions --means the FDA will expedite the development and review. 

However, they already have approval in most of Europe and Canada for mild to moderate cases of IPF, which is a chronic disease that causes inflammation and scarring of the lungs. The IPF market should be $1 billion by 2017, and probably will grow larger from there. And while this is not full approval, it certainly takes it one step closer.

The news makes this company a very attractive takeover target in an industry that's seeing a tidal wave of acquisitions. Even without a deal, I think this stock could drift higher and rally up at least to $55. I will say, because of the nature of this stock, I’m going to give you guys a stop-loss at $41.

DISCLOSURES

E-House China Holdings Ltd (EJ)

Owns

Family Owns

Firm Owns

Investment
Banking

CHARLES N N Y N
MATT N N N N
DANI N N N N

InterMune (ITMN)

Owns

Family Owns

Firm Owns

Investment
Banking

CHARLES N N Y N
MATT N N N N
DANI N N N N

 

All opinions expressed by the host and participants of "Making Money with Charles Payne" are solely their current opinions and do not reflect the opinions of FBN, Fox News Network, LLC or their parent companies or affiliates, and may have been previously disseminated by Payne or the show participants. Payne's and the show participants' opinions are based upon information they consider reliable, but neither FBN, nor its affiliates and/or subsidiaries, nor any companies with which such participants are affiliated, warrant their completeness or accuracy, and they should not be relied upon as such. No part of Payne's or the show participants' (if applicable) compensation from FBN is related to the specific opinions they express.

Past performance is not indicative of future results. Neither Payne, the show participants, nor FBN guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on the show. Strategies or investments discussed may fluctuate in price or value.

Investments or strategies mentioned in this show may not be suitable for you and you should make your own independent decision regarding them. This material does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. You should strongly consider seeking advice from your own investment adviser.

Charles Payne is the host of Making Money with Charles Payne (weekdays 6-7 PM/ET). Click here to see more from Charles Payne.